Investment of $9 million will help ensure Canadian innovators have the tools needed to develop treatments today and into the future December 18, 2020 – Ottawa, Ontario – National Research… Read More
Vancouver, British Columbia – December 18, 2020 – Qu Biologics Inc., a private clinical-stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore innate… Read More
Aurinia to receive $50 million U.S. upfront payment in addition to up to $50 million U.S. in regulatory and reimbursement milestone payments Agreement includes royalties of up to 20 percent… Read More
State-of-the-Art Monoplant Will Provide Cost and Production Efficiency and Secure Active Pharmaceutical Ingredient (API) Supply for Future Commercial Demand – VICTORIA, British Columbia–(BUSINESS WIRE)– Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH /… Read More
VANCOUVER, British Columbia–(BUSINESS WIRE)– Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced the selection of three abstracts for presentation at the American Society of Clinical… Read More
